These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25278321)

  • 21. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
    Kale HP; Patel AM; Carroll NV
    J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.
    Gellad WF; Huskamp HA; Li A; Zhang Y; Safran DG; Donohue JM
    J Gen Intern Med; 2011 Dec; 26(12):1458-64. PubMed ID: 21751052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food Insecurity and Health Outcomes Among Older Adults: The Role of Cost-Related Medication Underuse.
    Afulani P; Herman D; Coleman-Jensen A; Harrison GG
    J Nutr Gerontol Geriatr; 2015; 34(3):319-42. PubMed ID: 26267444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare Beneficiaries.
    Whaley C; Reed M; Hsu J; Fung V
    PLoS One; 2015; 10(12):e0144236. PubMed ID: 26642195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?
    Fairman KA; Curtiss FR
    J Manag Care Pharm; 2012 Mar; 18(2):146-55. PubMed ID: 22380473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Drug Price Paradox: Cost Analysis of Canadian Online Pharmacies versus US Medicare Beneficiaries for the Top 100 Drugs.
    Kim SH; Ryu YJ; Cho NE; Kim AE; Chang J
    Clin Drug Investig; 2017 Oct; 37(10):957-963. PubMed ID: 28735450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility.
    Liu FX; Alexander GC; Crawford SY; Pickard AS; Hedeker D; Walton SM
    Health Serv Res; 2011 Aug; 46(4):1104-23. PubMed ID: 21609328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans.
    Newman TV; Gabriel N; Liang Q; Drake C; El Khoudary SR; Good CB; Gellad WF; Hernandez I
    J Manag Care Spec Pharm; 2022 Feb; 28(2):266-274. PubMed ID: 35098746
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-related nonadherence in the Medicare program: the impact of Part D.
    Kennedy JJ; Maciejewski M; Liu D; Blodgett E
    Med Care; 2011 May; 49(5):522-6. PubMed ID: 21430574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the ExactCare medication care management model on adherence, health care utilization, and costs.
    Shetty KD; Chen AY; Rose AJ; Liu HH
    J Manag Care Spec Pharm; 2021 May; 27(5):574-585. PubMed ID: 33560167
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of Copayment Offsets for Prescription Drugs in the United States.
    Sen AP; Kang SY; Rashidi E; Ganguli D; Anderson G; Alexander GC
    JAMA Intern Med; 2021 Jun; 181(6):758-764. PubMed ID: 33779680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.
    Park T; Jung J
    J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
    Frankenfield DL; Howell BL; Wei II; Anderson KK
    Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability.
    Rogan EL; Ranson CA; Mori TK; Park SK; Lam HM; Legaspi JF; Tran LK; Cameros CJM; Blackburn AN; Lee ST; Valle-Oseguera CS; Pham CN; Woelfel JA; Patel RA
    Intellect Dev Disabil; 2019 Jun; 57(3):234-241. PubMed ID: 31120407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.
    Gu D; Shen C
    Drugs Aging; 2019 Dec; 36(12):1111-1121. PubMed ID: 31686403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cost sharing on prescription drug use by Medicare beneficiaries prior to the Medicare Drug Benefit and potential adverse selection in the benefit.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    J Am Pharm Assoc (2003); 2009; 49(1):18-25. PubMed ID: 19196592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.